Yu H - Search Results

1

Combined effects of furanodiene and doxorubicin on the migration and invasion of MDA-MB-231 breast cancer cells in vitro.

Zhong ZF, Tan W, Tian K, Yu H, Qiang WA, Wang YT. Zhong ZF, et al. Among authors: yu h. Oncol Rep. 2017 Apr;37(4):2016-2024. doi: 10.3892/or.2017.5435. Epub 2017 Feb 10. Oncol Rep. 2017. PMID: 28184941

2

[Study on analytical method for alkaloids in Bulbus Fritillariae cirrhosae].

Yu H, Jiang Y, Li P, Li SP, Wang YT. Yu H, et al. Zhongguo Zhong Yao Za Zhi. 2005 Apr;30(8):572-5. Zhongguo Zhong Yao Za Zhi. 2005. PMID: 16011276 Chinese.

3

Development of a high performance liquid chromatography-tandem mass method for determination of bis(7)-tacrine, a promising anti-Alzheimer's dimer, in rat blood.

Yu H, Ho JM, Kan KK, Cheng BW, Li WM, Zhang L, Lin G, Pang YP, Gu ZM, Chan K, Wang YT, Han YF. Yu H, et al. J Pharm Biomed Anal. 2007 Sep 3;44(5):1133-8. doi: 10.1016/j.jpba.2007.05.028. Epub 2007 May 25. J Pharm Biomed Anal. 2007. PMID: 17628383

4

The physicochemical properties and the in vivo AChE inhibition of two potential anti-Alzheimer agents, bis(12)-hupyridone and bis(7)-tacrine.

Yu H, Li WM, Kan KK, Ho JM, Carlier PR, Pang YP, Gu ZM, Zhong Z, Chan K, Wang YT, Han YF. Yu H, et al. J Pharm Biomed Anal. 2008 Jan 7;46(1):75-81. doi: 10.1016/j.jpba.2007.08.027. Epub 2007 Sep 4. J Pharm Biomed Anal. 2008. PMID: 17931815

5

Novel PI3K/AKT targeting anti-angiogenic activities of 4-vinylphenol, a new therapeutic potential of a well-known styrene metabolite.

Yue GG, Lee JK, Kwok HF, Cheng L, Wong EC, Jiang L, Yu H, Leung HW, Wong YL, Leung PC, Fung KP, Lau CB. Yue GG, et al. Among authors: yu h. Sci Rep. 2015 Jun 8;5:11149. doi: 10.1038/srep11149. Sci Rep. 2015. PMID: 26053458 Free PMC article.

6

Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma.

Cao HH, Chu JH, Kwan HY, Su T, Yu H, Cheng CY, Fu XQ, Guo H, Li T, Tse AK, Chou GX, Mo HB, Yu ZL. Cao HH, et al. Among authors: yu zl, yu h. Sci Rep. 2016 Feb 25;6:21731. doi: 10.1038/srep21731. Sci Rep. 2016. PMID: 26911838 Free PMC article.

7

The Typical Metabolic Modifiers Conferring Improvement in Cancer Resistance.

Tan W, Zhong Z, Wang S, Liu H, Yu H, Tan R, Hu X, Pan T, Wang Y. Tan W, et al. Among authors: yu h. Curr Med Chem. 2017 Nov 17;24(34):3698-3710. doi: 10.2174/0929867324666170203121449. Curr Med Chem. 2017. PMID: 28164760 Review.

8

Natural formulas and the nature of formulas: Exploring potential therapeutic targets based on traditional Chinese herbal formulas.

Zhang Q, Yu H, Qi J, Tang D, Chen X, Wan JB, Li P, Hu H, Wang YT, Hu Y. Zhang Q, et al. Among authors: yu h. PLoS One. 2017 Feb 9;12(2):e0171628. doi: 10.1371/journal.pone.0171628. eCollection 2017. PLoS One. 2017. PMID: 28182702 Free PMC article.

9

Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of α-tocopheryl succinate-based polyphosphoester copolymers.

Chen FQ, Zhang JM, Fang XF, Yu H, Liu YL, Li H, Wang YT, Chen MW. Chen FQ, et al. Among authors: yu h. Acta Pharmacol Sin. 2017 Jun;38(6):859-873. doi: 10.1038/aps.2016.150. Epub 2017 Mar 6. Acta Pharmacol Sin. 2017. PMID: 28260803 Free PMC article.

10

Furanodiene Induces Extrinsic and Intrinsic Apoptosis in Doxorubicin-Resistant MCF-7 Breast Cancer Cells via NF-κB-Independent Mechanism.

Zhong ZF, Yu HB, Wang CM, Qiang WA, Wang SP, Zhang JM, Yu H, Cui L, Wu T, Li DQ, Wang YT. Zhong ZF, et al. Among authors: yu hb, yu h. Front Pharmacol. 2017 Sep 14;8:648. doi: 10.3389/fphar.2017.00648. eCollection 2017. Front Pharmacol. 2017. PMID: 28959205 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,409 results

Search Page

Filters